| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.029 | 0.8 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.0064 | 0.8 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.0093 | 0.9 |